IIT Kharagpur

IIT Kharagpur Launches MSc Programmes in Nuclear Medicine and Medical Physics

IIT Kharagpur launches MSc programmes in nuclear medicine and medical physics with CNCI and VECC

IIT Kharagpur has taken a significant step in the field of medical education by launching Master of Science (MSc) programmes in Nuclear Medicine and Medical Physics. This initiative is a collaborative effort with the Chittaranjan National Cancer Institute (CNCI) and the Variable Energy Cyclotron Centre (VECC). The new programmes are set to commence in the academic session of 2026-27.

Collaboration Details

The collaboration between IIT Kharagpur, CNCI, and VECC aims to enhance the national capacity for skilled human resources in the domains of nuclear medicine and medical physics. These fields are crucial for cancer diagnosis, treatment, and advanced clinical research. The signing of a Memorandum of Understanding (MoU) marks the beginning of this important academic partnership.

Objectives of the Programmes

The MSc programmes are designed to train experts who will contribute to various aspects of cancer care, including:

  • Cancer diagnosis
  • Treatment methodologies
  • Advanced clinical research

By focusing on these areas, the programmes aim to equip students with the necessary skills and knowledge to address the growing challenges in cancer care and research.

Admission Process

Admissions for the MSc programmes will be conducted through the Joint Admission Test for Master’s (JAM). This entrance examination is a standardized test that evaluates the aptitude of candidates seeking admission to various postgraduate programmes across participating institutes.

Institutional Significance

The MoU was signed by key representatives from the three institutions:

  • Suman Chakraborty, Director of IIT Kharagpur
  • Dr. Jayanta Chakrabarti, Director of CNCI
  • Sumit Som, Director of VECC

This collaboration is particularly significant as it involves three Institutes of National Importance (INI), showcasing a united effort to advance medical education and research in India.

Vision for Healthcare Development

According to Suman Chakraborty, the Director of IIT Kharagpur, this MoU represents a major step toward the institute’s integrated vision of:

  • Medical education
  • Advanced clinical research
  • Technology-enabled healthcare delivery

The collaboration is not limited to academic programmes; it also envisions the development of advanced healthcare facilities at the Dr. Syama Prasad Mookerjee Super Speciality Hospital. Planned enhancements include:

  • Day-care chemotherapy services
  • Advanced radiology services
  • AI-driven cancer technologies

Importance of Nuclear Medicine and Medical Physics

Nuclear medicine and medical physics play pivotal roles in contemporary healthcare, particularly in oncology. These fields involve the use of radioactive materials for diagnosis and treatment, as well as the application of physics principles to medical technologies. The demand for professionals skilled in these areas is on the rise, driven by advancements in cancer treatment and the need for innovative diagnostic techniques.

Future Prospects

The introduction of these MSc programmes is expected to open new avenues for students and professionals in the healthcare sector. Graduates will be well-prepared to tackle the challenges of modern medicine, particularly in the context of cancer care. The collaboration between IIT Kharagpur, CNCI, and VECC signifies a commitment to fostering a skilled workforce capable of making significant contributions to healthcare in India and beyond.

Conclusion

The launch of MSc programmes in nuclear medicine and medical physics at IIT Kharagpur is a landmark initiative that underscores the importance of interdisciplinary collaboration in advancing medical education and research. By equipping students with the necessary skills and knowledge, these programmes aim to enhance the quality of cancer care and contribute to the overall improvement of healthcare delivery in the country.

Note: The information presented in this article is based on the latest updates as of January 31, 2026, and may be subject to change as new developments arise.

Disclaimer: A Teams provides news and information for general awareness purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of any content. Opinions expressed are those of the authors and not necessarily of A Teams. We are not liable for any actions taken based on the information published. Content may be updated or changed without prior notice.